½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1363807

¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø, Á¦Ç°º°, »ùÇú°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Self-Testing Market Size study & Forecast, by Product, by Sample, by Application and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÚ°¡ °Ë»ç´Â ȯÀÚ Ä¡·á ¹× °ü¸®¿¡¼­ ÃßÀû, Áø´Ü ¹× ´ëó¸¦ À§ÇÑ »õ·Î¿î ±âȸ¸¦ âÃâÇÏ°í ÀÖ½À´Ï´Ù.

Áúº´ÀÇ À§Ç輺À» ÆľÇÇϱâ À§ÇØ Á¦Á¶¾÷üµéÀº ±Þ¼º °¨¿° Áø´ÜºÎÅÍ ¸¸¼º Áúȯ °ü¸®±îÁö °Ç°­ ÁõÁø ¹× ¿¹¹æ Á¶Ä¡¸¦ À§ÇÑ °Ë»ç Å°Æ®¸¦ °³¹ßÇÏ°í ÀÖ½À´Ï´Ù. ¸¸¼º Áúȯ Ä¡·á¿¡¼­ ¿ÀÇÇ¿ÀÀ̵åÀÇ »ç¿ëÀÌ °è¼Ó Áõ°¡ÇÏ°í ¿À³²¿ë°ú °ü·ÃµÈ »ç¸Á·ü°ú ÀÌȯÀ²ÀÇ ³î¶ó¿î ºñÀ²ÀÌ ¹àÇôÁü¿¡ µû¶ó ÀÇ·á°èÀÇ ÅëÁõ °ü¸® Á¢±Ù ¹æ½ÄÀº ¾à¹° ³²¿ë °Ë»ç¸¦ ÅëÇÕÇÏ´Â °ÍÀÌ Áß¿äÇÑ Ãø¸éÀ¸·Î º¯È­ÀÇ ½Ã±â¸¦ ¸ÂÀÌÇÏ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº °¡Ä¡ ±â¹Ý ÀÇ·á Áõ°¡¿Í ¹Ì½ÂÀÎµÈ °¡Á¤¿ë COVID °Ë»ç Å°Æ®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù.

Statista¿¡ µû¸£¸é ¹Ì±¹Àº 2022³â 12¿ù 22ÀÏ ÇöÀç ¼¼°è¿¡¼­ °¡Àå ¸¹Àº Äڷγª19 °Ë»ç¸¦ ½Ç½ÃÇßÀ¸¸ç, ±× ¼ö´Â 11¾ï 5,000¸¸ °ÇÀ» ³Ñ¾î¼¹½À´Ï´Ù. ·¯½Ã¾Æ´Â 2¾ï 7,300¸¸ °Ç ÀÌ»óÀÇ °Ë»ç°¡ ÁøÇàµÇ¾úÀ¸¸ç, Äڷγª19ÀÇ À¯ÇàÀº ¼¼°è ÀÇ·á ½Ã½ºÅÛ¿¡ ½É°¢ÇÑ ºÎ´ãÀ» ¾È°ÜÁÖ¾ú½À´Ï´Ù. Àü¿°º´ÀÌ ½ÃÀÛµÈ Ãʱ⿡´Â °Ë»ç Å°Æ®¿¡ ´ëÇÑ ¼ö¿ä°¡ ¸Å¿ì ³ô¾ÒÁö¸¸ »ý»ê ´É·ÂÀº Á¦ÇÑÀûÀ̾ú½À´Ï´Ù. ¹Ì±¹ÀÇ Ãʱâ Àü¿°º´Àº Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ°¡ »ý»êÇÑ °Ë»ç Å°Æ®ÀÇ °áÇÔÀ¸·Î ÀÎÇØ ¸î ÁÖ µ¿¾È ¹ß°ßµÇÁö ¾Ê¾Ò½À´Ï´Ù. ±×·¯³ª °¡Â¥ °Ë»ç Áõ°¡´Â 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀÔ´Ï´Ù.

¼¼°è ÀÚ°¡ °Ë»ç ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ±â¼ú ¹ßÀü°ú °¡Á¤¿ë Å°Æ® »ç¿ë Áõ°¡·Î ÀÎÇØ ¼¼°è ½ÃÀå Á¡À¯À²À» ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸°¡ ¸¹°í ÀÚ°¡ Áø´Ü Å°Æ®ÀÇ ÆíÀǼº°ú ¼ö¿ë °¡´É¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆľÇÇÏ°í ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ¹ßÀü
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå ¿ªÇÐ

  • ÀÚ°¡ °Ë»ç ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • Æı«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : Á¦Ç°º°, ½ÇÀû¡¤°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ÀÚ°¡ °Ë»ç ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Áø´Ü Å°Æ®
    • Áø´Ü µð¹ÙÀ̽º
    • Áø´Ü ½ºÆ®¸³

Á¦6Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : »ùÇú°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : »ùÇú° ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : »ùÇú°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ÀÚ°¡ °Ë»ç ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ¼Òº¯
    • Ç÷¾×
    • ´ëº¯
    • ±¸°­ ½º¿Ò
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : ¿ëµµº° ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ÀÚ°¡ °Ë»ç ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ÄÝ·¹½ºÅ×·Ñ ¹× Áß¼º Áö¹æ °Ë»ç
    • ´ç´¢º´ ¹× ±Û·çÄÚ¿À½º °Ë»ç
    • ¹è¶õ °Ë»ç ¹× ¾Ï °Ë»ç
    • ºÒ³»Áõ ¶Ç´Â ¼¿¸®¾Çº´ °Ë»ç
    • ¾Ë·¹¸£±â °Ë»ç
    • ºóÇ÷ °Ë»ç

Á¦8Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå, Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ÀÚ°¡ °Ë»ç ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • »ùÇú°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Piramal Enterprises Ltd
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
    • Quidel Corporation
    • ARKRAY Inc.
    • True Diagnostics Inc.
    • ACON Laboratories Inc.
    • Assure Tech(Hangzhou) Co. Ltd.
    • Becton Dickinson & Company
    • Bionime Corporation
    • Roche Holding AG
    • True Diagnostics Inc.

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.11.06

Self-Testing is creating new opportunities for tracking, diagnosing, and addressing in patients treatment and their care. To identify the possible hazards of illnesses, manufacturers are creating testing kits for wellness and preventative measures, spanning from acute infection diagnosis to chronic condition management. As the utilization of opioids for chronic illness treatment continues to increase and the alarming rates of mortality and morbidity linked to their misuse become apparent, pain management approaches within the medical community are undergoing transformation with the integration of substance abuse testing as a crucial aspect. The market growth is driven by key factors such as increasing value-based care and growing demand for unauthorized home COVID kits for testing.

According to Statista, The United States has conducted the most COVID-19 tests globally as of December 22, 2022, with over 1.15 billion tests. There have been more than 273 million tests in Russia. The COVID-19 epidemic has severely taxed health systems all around the world. There was a tremendous demand for test kits at the start of the epidemic, but production capacity was limited. The early outbreak of the disease in the United States was undiscovered for weeks due to defective testing kits made by the Centers for Disease Control and Prevention. However, the rising number of false tests stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Self-Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market share owing to increased technology advancement and use of home kits. On the other side, Asia Pacific is expected to be the fastest growing region due to its large population and growing awareness about the convenience and acceptability of self-testing kits.

Major market player included in this report are:

  • Piramal Enterprises Ltd
  • Quidel Corporation
  • ARKRAY Inc.
  • True Diagnostics Inc.
  • ACON Laboratories Inc.
  • Assure Tech (Hangzhou) Co. Ltd.
  • Becton Dickinson & Company
  • Bionime Corporation
  • Roche Holding AG
  • True Diagnostics Inc.

Recent Developments in the Market:

  • In January 2022, Florida Atlantic University (FAU) granted around USD 1.3 million to NIH for the development of automated, quick HIV self-kits. After a programmatic evaluation of the results of the first phase's progress, another USD 1.3 million would be granted for this endeavour.
  • In January 2023, The NIH and Administration for Strategic Preparedness and Response (ASPR) collaborated to launch the Home Test to Treat programme. This virtual community health intervention would provide free COVID health services in a few selected communities, including telehealth consultations, home treatments, and at-home rapid tests.

Global Self-Testing Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Sample, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Diagnostic kits
  • Diagnostic device
  • Diagnostic strips

By Sample:

  • Urine
  • Blood
  • Stools
  • Oral Swabs
  • Other

By Application:

  • Cholesterol and Triglycerides Tests
  • Diabetes and Glucose Tests
  • Ovulation Test Cancer Test
  • Intolerance or Celiac disease Test
  • Allergy Test
  • Anemia Test

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Self-Testing Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Self-Testing Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Self-Testing Market, by Sample, 2020-2030 (USD Billion)
    • 1.2.4. Self-Testing Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Self-Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Self-Testing Market Dynamics

  • 3.1. Self-Testing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing value-based care
      • 3.1.1.2. Growing demand for unauthorized home COVID kits for testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Rising number of false tests
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rapid adoption of online purchasing

Chapter 4. Global Self-Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Self-Testing Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Self-Testing Market by Product, Performance - Potential Analysis
  • 5.3. Global Self-Testing Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Self-Testing Market, Sub Segment Analysis
    • 5.4.1. Diagnostic kits
    • 5.4.2. Diagnostic device
    • 5.4.3. Diagnostic strips

Chapter 6. Global Self-Testing Market, by Sample

  • 6.1. Market Snapshot
  • 6.2. Global Self-Testing Market by Sample, Performance - Potential Analysis
  • 6.3. Global Self-Testing Market Estimates & Forecasts by Sample 2020-2030 (USD Billion)
  • 6.4. Self-Testing Market, Sub Segment Analysis
    • 6.4.1. Urine
    • 6.4.2. Blood
    • 6.4.3. Stools
    • 6.4.4. Oral Swabs
    • 6.4.5. Other

Chapter 7. Global Self-Testing Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Self-Testing Market by Application, Performance - Potential Analysis
  • 7.3. Global Self-Testing Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Self-Testing Market, Sub Segment Analysis
    • 7.4.1. Cholesterol and Triglycerides Tests
    • 7.4.2. Diabetes and Glucose Tests
    • 7.4.3. Ovulation Test Cancer Test
    • 7.4.4. Intolerance or Celiac disease Test
    • 7.4.5. Allergy Test
    • 7.4.6. Anemia Test

Chapter 8. Global Self-Testing Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Self-Testing Market, Regional Market Snapshot
  • 8.4. North America Self-Testing Market
    • 8.4.1. U.S. Self-Testing Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Sample breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Self-Testing Market
  • 8.5. Europe Self-Testing Market Snapshot
    • 8.5.1. U.K. Self-Testing Market
    • 8.5.2. Germany Self-Testing Market
    • 8.5.3. France Self-Testing Market
    • 8.5.4. Spain Self-Testing Market
    • 8.5.5. Italy Self-Testing Market
    • 8.5.6. Rest of Europe Self-Testing Market
  • 8.6. Asia-Pacific Self-Testing Market Snapshot
    • 8.6.1. China Self-Testing Market
    • 8.6.2. India Self-Testing Market
    • 8.6.3. Japan Self-Testing Market
    • 8.6.4. Australia Self-Testing Market
    • 8.6.5. South Korea Self-Testing Market
    • 8.6.6. Rest of Asia Pacific Self-Testing Market
  • 8.7. Latin America Self-Testing Market Snapshot
    • 8.7.1. Brazil Self-Testing Market
    • 8.7.2. Mexico Self-Testing Market
  • 8.8. Middle East & Africa Self-Testing Market
    • 8.8.1. Saudi Arabia Self-Testing Market
    • 8.8.2. South Africa Self-Testing Market
    • 8.8.3. Rest of Middle East & Africa Self-Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Piramal Enterprises Ltd
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Quidel Corporation
    • 9.3.3. ARKRAY Inc.
    • 9.3.4. True Diagnostics Inc.
    • 9.3.5. ACON Laboratories Inc.
    • 9.3.6. Assure Tech (Hangzhou) Co. Ltd.
    • 9.3.7. Becton Dickinson & Company
    • 9.3.8. Bionime Corporation
    • 9.3.9. Roche Holding AG
    • 9.3.10. True Diagnostics Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦